Cue Biopharma, Inc. (CUE) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CUE currently has 4.05M outstanding shares. with significant dilution risk as 60M authorized shares could dilute existing holders by 1483.7%. The company has significantly diluted shareholders by 58.08% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jun 03, 2026 |
S-3 filing: The filing relates to the registration for resale of 4,090,908 shares of common stock issuable upon the exercise of outstanding pre-funded warrants and warrants held by selling stockholders. |
4M | 60M |
| May 14, 2026 |
10-Q filing | 4.0M shares outstanding |
4M | 56M |
| May 12, 2025 |
10-Q filing | 74.3M shares outstanding |
74M | 0 |
| Mar 31, 2025 |
10-K filing | 56.3M shares outstanding |
56M | 3.7M |
| Nov 14, 2024 |
10-Q filing | 63.4M shares outstanding |
63M | 0 |
| Aug 14, 2024 |
10-Q filing | 50.2M shares outstanding |
50M | 9.8M |
| May 09, 2024 |
10-Q filing | 49.5M shares outstanding |
49M | 11M |
| Mar 28, 2024 |
10-K filing | 45.8M shares outstanding |
46M | 14M |
| Nov 03, 2023 |
10-Q filing | 46.4M shares outstanding |
46M | 14M |
| Aug 08, 2023 |
10-Q filing | 44.8M shares outstanding |
45M | 15M |
| May 09, 2023 |
S-3 filing: The company is filing an S-3 to register the offering of debt securities, common stock, preferred stock, and subscription rights, with a total aggregate offering price of up to $300,000,000. They are also offering common stock through an at-the-market offering. |
43M | 17M |
| May 09, 2023 |
10-Q filing | 44.7M shares outstanding |
45M | 15M |
| Mar 21, 2023 |
10-K filing | 43.2M shares outstanding |
43M | 5.5M |
| Dec 06, 2022 |
S-3 filing: This S-3 filing relates to the resale from time to time of up to 18,376,812 shares of common stock of Cue Biopharma, Inc. by the selling stockholders. |
35M | 13M |
| Nov 14, 2022 |
10-Q filing | 35.4M shares outstanding |
35M | 0 |
| Aug 04, 2022 |
10-Q filing | 35.4M shares outstanding |
35M | 0 |
| May 10, 2022 |
10-Q filing | 35.4M shares outstanding |
35M | 0 |
| Mar 16, 2022 |
10-K filing | 33.0M shares outstanding |
33M | 0 |
| Nov 09, 2021 |
10-Q filing | 31.8M shares outstanding |
32M | 0 |
| Aug 09, 2021 |
10-Q filing | 31.5M shares outstanding |
32M | 0 |
| May 21, 2021 |
POS AM filing: The filing is a POS AM filing for an offering of common stock, preferred stock and debt securities with an aggregate value of up to $300,000,000. |
31M | 0 |
| May 10, 2021 |
10-Q filing | 31.4M shares outstanding |
31M | 0 |
| Mar 09, 2021 |
10-K filing | 30.5M shares outstanding |
30M | 0 |
| Mar 09, 2021 |
POS AM filing: The company is filing a POS AM to register the offer and sale of up to $300,000,000 in the aggregate of common stock, preferred stock and debt securities from time to time in one or more offerings. |
30M | 0 |
| Nov 09, 2020 |
10-Q filing | 30.3M shares outstanding |
30M | 0 |
| Aug 07, 2020 |
10-Q filing | 29.5M shares outstanding |
29M | 0 |
| May 07, 2020 |
10-Q filing | 28.4M shares outstanding |
28M | 0 |
| Mar 12, 2020 |
10-K filing | 26.6M shares outstanding |
27M | 0 |